Ryboquin raises £1.8m for drug development in gene therapy – Drug Target Review
Drug Target Review |
Ryboquin raises £1.8m for drug development in gene therapy
Drug Target Review Ryboquin Limited announces that it has closed a £1.8m equity fund raising to accelerate product development in gene therapy. Tycoons fund biotech firm with ambitions to 'revolutionise' cancer … |
